A CTL-based liposomal vaccine capable of inducing protection against heterosubtypic influenza viruses in HLA-A*0201 transgenic mice

Biochemical and Biophysical Research Communications

Volumn 391, Issue 3, 2010, Pages 1494-1499

  Matsui, Masanori ^a   Kohyama, Shunsuke ^a   Suda, Tatsuya ^a   Yokoyama, Shoichi ^b   Mori, Masahito ^b   Kobayashi, Akiharu ^b   Taneichi, Maiko ^c   Uchida, Tetsuya ^c  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b NOF Corporation   (Japan)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

CTL; Influenza; Liposome; Vaccine

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; EPITOPE; GLYCYLISOLEUCYLLEUCYLGLYCYLPHENYLALANYLVALYLPHENYLALANYLTHREONYLLEUCINE; INFLUENZA VACCINE; UNCLASSIFIED DRUG; VIRUS ANTIGEN;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DRUG SCREENING; EXPERIMENTAL INFECTION; IMMUNITY; IMMUNIZATION; INFLUENZA; INFLUENZA VIRUS; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; LIPOSOMAL DELIVERY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE; VIRUS REPLICATION;

AMINO ACID SEQUENCE; ANIMALS; EPITOPES, T-LYMPHOCYTE; HLA-A ANTIGENS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; LIPOSOMES; MICE; MICE, TRANSGENIC; PEPTIDE FRAGMENTS; T-LYMPHOCYTES, CYTOTOXIC;

INFLUENZA A VIRUS; MUS; MUS MUSCULUS; ORTHOMYXOVIRIDAE;

EID: 73949118947     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.12.100     Document Type: Article

References (25)

1. CDC. Morbidity and Mortality Weekly Report, Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR 58 (2009) 521-524
2. Gatherer D. The 2009 H1N1 influenza outbreak in its historical context. J. Clin. Virol. 45 (2009) 174-178
3. Olsen B., Munster V.J., Wallensten A., et al. Global patterns of influenza A virus in wild birds. Science 312 (2006) 384-388
4. Effors R.B., Doherty P.C., Gerhard W., et al. Generation of both cross-reactive and virus-specific T-cell populations after immunization with serologically distinct influenza A viruses. J. Exp. Med. 145 (1977) 557-568
5. Kreijtz J.H.C.M., Mutsert G., Baalen C.A., et al. Cross-recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virus. J. Virol. 82 (2008) 5161-5166
6. Lee L.Y., Ha D.L.A., Simmons C., et al. Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals. J. Clin. Invest. 118 (2008) 3478-3490
7. Heath W.R., and Carbone F.R. Cross-presentation, dendritic cells, tolerance and immunity. Annu. Rev. Immunol. 19 (2001) 47-64
8. Glenny A.T., and Pope C.G. Immunology notes. XXIII. The antigenic value of toxoid precipitated by potassium alum. J. Pathol. Bacteriol. 29 (1926) 31-40
9. Aggrebeck H., Wantzin J., and Heon I. Booster vaccination against diphtheria and tetanus in man: comparison of three different vaccine formations-III. Vaccine 14 (1996) 1265-1272
10. + T cells and induce potent antitumor immunity. J. Immunol. 177 (2006) 2324-2330
11. Uchida T., and Taneichi M. Clinical application of surface-linked liposomal antigens. Mini Rev. Med. Chem. 8 (2008) 184-192
12. Nagata T., Toyota T., Ishigaki H., et al. Peptides coupled to the surface of a kind of liposome protect infection of influenza viruses. Vaccine 25 (2007) 4914-4921
13. b β2m double knockout mice. J. Exp. Med. 185 (1997) 2043-2051
14. Gotch F., Rothbard J., Howland K., et al. Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2. Nature 326 (1987) 881-882
15. Cottey R., Rowe C.A., and Bender B.S. Influenza virus. Current Protocols in Immunology (2001), John Wiley & Sons Inc. 19.11.1-19.11.32
16. Matsui M., Moriya O., and Belladonna M.L. Adjuvant activities of novel cytokines, interleukine (IL)-23 and IL-27 for induction of hepatitis C virus-specific cytotoxic T lymphocytes in HLA-A*0201 transgenic mice. J. Virol. 78 (2004) 9093-9104
17. + T cell responses. J. Exp. Med. 198 (2003) 889-901
18. Epstein S.L., Kong W., Miplon J.A., et al. Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein. Vaccine 23 (2005) 5404-5410
19. Townsend A.R.M., Rothbard J., Gotch F.M., et al. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell 44 (1986) 959-968
20. Berkhoff E.G.M., Wit D., Geelhoed-Mieras M.M., et al. Functional constrains of influenza A virus epitopes limit escape from cytotoxic T lymphocytes. J. Virol. 79 (2005) 11239-11246
21. Doherty P.C., and Kelso A. Toward a broadly protective influenza vaccine. J. Clin. Invest. 118 (2008) 3273-3275
22. Thomas P.G., Keating R., Hulse-Post D.J., et al. Cell-mediated protection in influenza infection. Emerg. Infect. Dis. 12 (2006) 48-54
23. Tanaka Y., Kasai M., Taneichi M., et al. Liposomes with differential lipid components exert differential adjuvanticity in antigen-liposome conjugates via differential recognition by macrophages. Bioconjug. Chem. 15 (2004) 35-40
24. Taneichi M., Naito S., Kato H., et al. T cell-independent regulation of IgE antibody production induced by surface-linked liposomal antigen. J. Immunol. 169 (2002) 4246-4252
25. Nakano Y., Mori M., Nishinohara S., et al. Surface-linked Liposomal antigen induces IgE-selective unresponsiveness regardless of the lipid components of liposomes. Bioconjug. Chem. 12 (2001) 391-395